{"id":"tp-44381","type":"article-newspaper","title":"Helix BioPharma Reports Fiscal 2026 Loss of C$0.04 Per Share","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/44381","datePublished":"2026-10-30T07:29:46.000Z","dateModified":"2026-10-30T07:29:46.000Z","language":"en","abstract":"The loss narrowed from C$0.09 per share a year earlier. Cash reserves were C$804,000 on July 31, compared with C$65,000 a year earlier.","section":"Business","references":[]}